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Rap1 is a small GTP-binding protein (SMG) that exists in two 95% homologous
isoforms, rap1A and rap1B. The functions of the rap1 proteins are not well under-
stood. In this report we examined expression and function of rap1 in primary
(HOKs) and immortalized (IHOKs) human oral keratinocytes under different
growthconditions. InHOKs, rap1 increasedwith passagenumber, suggesting a role
in differentiation and arrest of proliferation. Similarly, when inhibition of proli-
feration and differentiationwere induced inHOKs by 1.2mMCaCl2, both rap1 and
involucrin increased with increasing concentrations of CaCl2. However, when
similar experiments were done with IHOKs, which continue to proliferate in the
presence of 1.2 mM CaCl2, the increase in involucrin expression was similar to
HOKs but there was no substantial increase in rap1, suggesting that increased
expression of rap1 is linked to inhibition of proliferation rather than differentiation
of keratinocytes. Upon transfection of immortalized keratinocytes with rapGAP,
which inactivates both isoforms of endogenous active rap1, enhanced proliferation
was observed. Thus, we conclude that rap1 inhibits proliferation in keratino-
cytes. J. Cell. Physiol. 196: 532–540, 2003.  2003 Wiley-Liss, Inc.
Small GTP-binding proteins (SMGs) are divided into
five subfamilies, namely ras, rho, rab, arf, and ran
(Vojtek and Der, 1998). Members of these subfamilies
regulate their functions by shuttling between inactive
GDP- and active GTP-bound states. In general, ras sub-
family proteins are key players in receptor-linked
signaling pathways that control cell growth and differ-
entiation (Bokoch, 1993; Wagner and Williams, 1994).
Ras and rap1 are members of the ras subfamily. Growth
factor-induced ras-activation triggers the mitogen acti-
vated protein kinase (MAPK) signaling cascade, which
culminates in gene transcription, cell proliferation or
differentiation (Herrmann and Nassar, 1996).
Persistent up-regulation of the ras-signaling pathway
facilitates uncontrolled cell proliferation and malignant
transformation via the MAPK pathway. Ras is one of the
most frequently mutated oncogenes in cancer (Barbacid,
1987; Grunicke and Maly, 1993) but ras mutations are
not always detected in tumor cells with an aberrantly
upregulated MAPK pathway (Vojtek and Der, 1998). Of
particular interest is that ras mutations have been
identified in only 5% of oral squamous cell carcinomas
occurring in patients in the Western hemisphere, in
contrast to 35% in India and Southeast Asia where
betel nut chewing and reverse smoking are prevalent
(Saranath et al., 1991; Clark et al., 1993; Jordan and
Daley, 1997).
Mutations or activation of other ras-like proteins may
play a role in oral carcinogenesis because SMGs are
integral members of the growth cycle (Bokoch, 1993).
Rap1 is a ras-like protein that appears to have a role in
cell proliferation (Kitayama et al., 1989; Yoshida et al.,
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1992; Altschuler and Ribeiro-Neto, 1998). It is a
ubiquitously expressed protein that has two isoforms,
rap1A and rap1B, products of different genes located on
chromosomes 1 and 12, respectively (Noda, 1993).
Rap1A, also called smg p21 or Krev1, is 95% homologous
to rap1B, from which it differs by only 9 amino acids (of a
total of 184). Six of these are located in the C-terminus
between amino acid residues 171–184 (Bokoch, 1993).
Rap1 is closely homologous to ras in the ras transfor-
mation domains, which include the GTP-binding region,
effector domain, and membrane attachment site (Far-
rell et al., 1992). The identical effector domains of ras
and rap1 suggested an antagonistic or complementary
role in the same signaling pathway (Altschuler et al.,
1995). In fact, rap1A was originally identified as a ras-
tumor suppressor gene in ras transformed NIH 3T3
fibroblasts (Kitayama et al., 1989). Rap1A was postu-
lated to function by competitively inhibiting ras GTPase
activating protein (rasGAP), a ras effector (Kitayama
et al., 1989). Furthermore, rap1A was also shown to
facilitate cell proliferation by inducing DNA synthesis
when microinjected into Swiss 3T3 cells (Yoshida et al.,
1992). Rap1B, the other rap1 isoform, has been reported
to induce proliferation and morphologic transformation
of Swiss 3T3 cells (Altschuler and Ribeiro-Neto, 1998).
In neuronal cells, rap1B acts independently of ras, via
the MAPK cascade to promote differentiation (Vossler
et al., 1997). Thus, there is confusion regarding the
functions of the rap1 isoforms.
Due to the diversity of opinions regarding the func-
tions of rap1A and rap1B, it is important to investigate
the functions of these proteins in the context of a specific
cell type. Although the majority of tumors are epithelial
in origin (>80%), the role of rap1 in growth and dif-
ferentiation of epithelial cells remains relatively un-
explored. In the present study, we investigated the
expression and function of rap1A and rap1B in human
oral keratinocytes and show that active rap1-GTP is
upregulated in differentiating keratinocytes and that it
inhibits proliferation. Hence, rap1 may have a tumor
suppressor role in oral epithelium.
MATERIALS AND METHODS
Cell culture
Primary oral keratinocytes were cultured from
human gingival tissue as described previously (Oda
and Watson, 1990). Discarded gingival tissue from third
molar extraction sites or from periodontal surgery, was
collected (after appropriate Institutional Review Board
for Human Subject Research approval) in PBS with
antibiotic/antimycotic (penicillin 200 U/mlþ streptomy-
cin 200 mg/mlþamphotericin B 50 mg/ml; GIBCO,
Carlsbad, CA), washed extensively in the same media,
and incubated overnight in 4 mg/ml Dispase (Collabora-
tive Biomedical/Becton Dickinson, Bedford, MA). The
epithelium was dissociated from the connective tissue,
trypsinized and dispersed into single cells and seeded
and grown in low-Ca2þ (0.03 mM CaCl2), serum-free
Keratinocyte Growth Medium (KGM, Biowhittaker/
Clonetics Corp., Walkersville, MD). This was designated
P1 (passage 1). Keratinocytes were routinely passaged
using 0.05% trypsin/0.53 mM EDTA. Keratinocytes
between passage numbers 1 and 4 were used. An
HPV16 immortalized human oral keratinocyte cell line
(HOK 16B, gift from Dr. No-Hee Park, University of
California, Los Angeles) was maintained in low-Ca2þ
KGM (Park et al., 1991).
Treatment of cells with high Ca2þ
To analyze calcium-induced changes in keratinocytes,
cells were cultured for 3 or 7 days in KGM supplemented
with 1.2 mM CaCl2.
Proliferation assay
Keratinocyte proliferation was measured by seeding
approximately 15,000–20,000 cells per well in a 24-well
culture plate in KGM. One day later, the cells were
washed and incubated in KGM or KGM supplemented
with 1.2 mM CaCl2 (day 0). Media was changed on d0,
d2, d4, and d6. Cells were counted on d0, d1, d3, d5
and d7. After the appropriate incubation period, the
wells were washed once with PBS and the cells were
harvested with trypsin/EDTA and counted with a
hemocytometer. Cell viability was assessed on the basis
of Trypan blue exclusion. Values represent means and
standard deviation based on three wells per data point in
a single experiment. The experiment was repeated at
least three times with similar results.
Western blot analysis
For the preparation of lysates, keratinocytes were
washed once with ice-cold PBS and lysed in 1% Nonidet-
P40 lysis buffer containing protease inhibitors on ice
for 15 min. The particulate material was pelleted by
centrifugation at 15,700g for 10 min at 48C. The super-
natant was collected and protein content was measured
by the Bio-Rad protein assay (Bio-Rad, Richmond, CA).
Equal amounts of protein (25–50 mg) or equivalent cell
numbers, were electrophoresed on SDS/12% polyacry-
lamide gels and transferred to nitrocellulose mem-
branes (Schleicher and Schuell, Keene, NH). Prior to
blocking, the membrane was stained with Ponceau S
for verification of equivalency of protein loading and
efficient transfer. The membranes were incubated in
5% non-fat dry milk in Tris-buffered saline (TBS) for
1 h at room temperature (RT) to block non-specific
binding. Membranes were placed in the primary anti-
body for 1 h at RT or overnight at 48C. Primary anti-
body concentrations were: rabbit anti-rap1 affinity
purified polyclonal antibody (1:150, Santa Cruz, CA);
mouse anti-involucrin AB-1 (Sy5) monoclonal antibody
(1:1000; Neomarkers, Fremont, CA); or mouse anti-
GAPDH (1:5000; Chemicon International, Temecula,
CA). Membranes were washed in TBS containing 0.1%
Tween-20 (TBS-T) (Bio-Rad). Affinity-purified horse-
radish peroxidase-linked donkey anti-rabbit or goat
anti-mouse IgG (Jackson ImmunoResearch Labora-
tories, West Grove, PA) as a secondary antibody were
used to detect primary antibodies. Visualization of
the immunoreactive proteins was accomplished by
the chemiluminescence system (Amersham, Arlington
Heights, IL or Pierce, Rockford, IL) and exposure to film.
Cell immunostaining
Cultured HOKs were fixed in acetone and methanol,
air dried, and stained for rap1 and involucrin as follows.
Slides were incubated with rabbit anti-rap1, mouse anti-
involucrin, rabbit IgG or mouse IgG, for 1 h at RT. For
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double immunofluorescence labeling, the slides were
initially treated with rabbit anti-rap1 polyclonal anti-
body or rabbit IgG followed by immunodetection
using FITC (fluorescein isothiocyanate)-conjugated
donkey anti-rabbit IgG (Jackson Immunoresearch).
The washed slide was subsequently stained with mouse
anti-involucrin or mouse IgG, washed with PBS, and
then exposed to Texas red conjugated goat anti-mouse
IgG (Jackson Immunoresearch). The cells were visua-
lized on a laser scanning confocal microscope (MRC600,
Bio-Rad). Slides were photographed with a 63 oil
immersion lens, digitized and processed with Adobe
Photoshop software (ver 5.0, San Jose, CA).
[a-32P] GTP-blot overlay assay
Low molecular mass GTP-binding proteins were
detected by the radiolabeled GTP-blot overlay method
as described previously (D’Silva et al., 1997). Briefly, cell
lysates and molecular weight standards were separat-
ed by SDS 12% PAGE, transferred to nitrocellulose
membranes and blocked with GTP-binding buffer (0.3%
Tween-20, 5 mM MgCl2, 1 mM potassium phosphate,
100 mM ATP, 50 mM Tris-HCl, pH 7.5). Subsequently,
the membranes were incubated in the same buffer
containing 100 mM DTT and 1 mCi [a-32P]-GTP/ml
(Dupont-New England Nuclear Research Products,
Boston, MA), with or without unlabeled 100 mM GTP
for 60 min at RT. The membranes were washed in the
same buffer without DTT, were air dried and exposed to
autoradiographic film for 1 h to 7 day.
Total RNA isolation
RNA was isolated from cell pellets or cells in culture
dishes using the Total RNAEasy kit (Qiagen, Bothell,
WA) or TRIZOL (GIBCO), using the respective manu-
facturer’s protocol.
Real time reverse transcriptase polymerase
chain reaction (Q-RT-PCR)
Real time RT-PCR was performed using the Perkin-
Elmer TaqMan system (PE Applied Biosystems,
Foster City, CA) (Heid et al., 1996). Briefly, two sets of
rap1 isoform-specific primers were designed in exons
that spanned the intron–exon boundaries in the
region corresponding to the C-termini of rap1A and
rap1B (Rap1A—forward primer: CGGGTTAAGGACA-
CGGAAGA, reverse primer: TCTTTGCCAACTACTC-
GCTCATC, TaqMan probe: TGATTTTGGTTGGCAA-




TG). The primers did not amplify genomic DNA and
demonstrated isoform specificity when tested against
plasmids containing either the rap1A or rap1B cDNA
sequences (kind gift from Dr. Veronique Pizon, Institut
Andre Lwoff, France). The TaqMan probes, which are
designed to bind to the middle of the regions being
amplified, have reporter and quencher fluorescent dye
molecules attached to each probe. During the extension
cycle, the reporter dye is cleaved by the nuclease com-
ponent of the polymerase. This releases the reporter
from the quencher, thereby allowing the reporter to
fluoresce. This fluorescence is quantified and during the
logarithmic phase of the reaction is proportional to the
amount of RNA being amplified.
Transfections
pcDNA 3.1-rapGAP plasmid was a kind gift from
Dr. P. Stork (Oregon Health Sciences University, OR).
The pcDNA 3.1 empty vector was used as a control for
transfection effects on endogenous gene expression.
Transfection efficiency was assessed with the pcDNA
3.1-b-galactosidase plasmid and commercially available
detection reagent (Boehringer, Mannheim, Germany)
followed by enumeration of positive staining cells per
hundred cells in 25 high power fields.
For proliferation assays on transfected keratino-
cytes, immortalized keratinocytes were seeded at
200,000 cells/dish in 60 mm dishes. Two days later
the cells were transfected with Effectene (Qiagen, CA)
according to the manufacturer’s instructions in DMEM/
FBS. Media was changed to KGM 24 h after transfec-
tion. The total number of cells was counted on the day of
transfection and at 24 h intervals thereafter for 4 day as
described above.
Rap1 activation assay
The rap-binding domain of ral-GDS binds only the
active form of rap1 (Franke et al., 1997). The construct
for ral-GDS was a generous gift from Dr. Johannes L.
Bos (University Medical Centre Utrecht, The Nether-
lands). Glutathione S-transferase (GST) tagged ral-
GDS was purified from bacterial cells expressing the
protein and used to pull-down the active form of rap1B,
as described previously (Franke et al., 1997).
Data analysis
Molecular mass determination of SMGs in Figure 1,
was done using AlphaeaseTM software, version 5.5
(Alpha Innotech Corporation, San Leandro, CA). Sta-
tistical analysis was done by a Student’s t-test.
RESULTS
Rap1 expression is upregulated in consecutive
passages of keratinocytes
Small GTP-binding proteins from the ras subfamily
have been shown to play a role in proliferation or
differentiation of cells. Hence, in initial experiments,
rap1 expression was investigated in sequential passages
of primary keratinocytes. Primary normal human oral
keratinocytes (HOK) may be cultured in vitro for ap-
proximately 3–5 passages before the cells no longer
proliferate (Oda and Watson, 1990). This cessation of
proliferation has been attributed to aging and/or differ-
entiation (Norsgaard et al., 1996). Cell lysates were
prepared from sequential passages of freshly isolated
adult HOKs until the cells ceased to proliferate, usually
about 3–4 passages in our experiments. Lysates were
normalized to cell number and were assayed for the
presence of SMGs, particularly rap1. When separated by
gel electrophoresis and immobilized on a nitrocellulose
membrane, at least three SMG proteins with molecular
weights of 22, 24, and 27 kDa, were detected by GTP
overlay (Fig. 1A). There was increased binding of
[a-32P]-GTP in each sequential passage of these pri-
mary oral keratinocytes (Fig. 1A). On an exact repli-
cate membrane, an excess of unlabeled GTP (100 mM)
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successfully competed for radiolabeled GTP thereby
showing specificity of binding for these peptides
(Fig. 1B). However, the presence of 100 mM ATP in the
binding buffer did not eliminate [a-32P]-GTP binding
thereby confirming nucleotide specificity (Fig. 1A).
Thus, at least three SMGs are upregulated in sequential
passages of HOKs.
As shown in Figure 1C and F, when the membrane
from Figure 1B was probed with anti-rap1 antibody,
rap1 was upregulated in the NP40-soluble fraction of
sequential passages of HOKs. To evaluate whether
this upregulation occurs concurrently with induction of
differentiation, the same membrane was blotted again
with a mouse anti-involucrin antibody. As shown in
Figure 1D, involucrin was upregulated in sequential
passages of HOKs. Equivalency of loading was assayed
by blotting the same membrane a third time with mouse
anti-GAPDH (glyceraldehyde-3-phosphate dehydro-
genase) monoclonal antibody (Fig. 1E). Thus, rap1 is
one of the SMGs upregulated in terminally differentiat-
ing HOKs.
Both rap1 isoforms are expressed but neither is
transcriptionally upregulated in terminally
differentiated keratinocytes
To verify which rap1 isoform is upregulated in
sequential passages of HOKs, we performed real time
RT-PCR. Both rap1A and rap1B mRNAs were present in
sequential passages of primary HOKs (Fig. 2). In all
passages, Rap1B mRNA was 10-fold higher than that
of rap1A. No upregulation in either mRNA was noted
between P1 and subsequent passages, suggesting that
differences in protein expression may be translationally
regulated.
Rap1 actuvation is correlated with
inhibition of proliferation
Since terminal differentiation involves both growth
inhibition and expression of differentiation markers,
further studies were conducted to investigate the asso-
ciation between rap1 and these two processes in
keratinocytes. For these studies we took advantage of
the disparity in growth inhibitory effects induced by
CaCl2 in primary and immortalized keratinocytes.
Proliferation assays were performed on primary and
immortalized keratinocytes in the presence of 0.03 and
1.2 mM CaCl2. In primary HOKs, proliferation increas-
ed significantly at day 1 and started to plateau at day 3,
following addition of 1.2 mM CaCl2 (Fig. 3A). By day 7,
the total cell number plateaued in the cells grown in
0.03 mM CaCl2 and decreased in the cells grown in
1.2 mM CaCl2. In contrast to primary HOKs, the IHOKs
showed no CaCl2-induced (1.2 mM) increase in prolif-
eration at day 1 (Fig. 3B). Instead the cell number
increased in both control (0.03 mM) and 1.2 mM CaCl2-
treated samples linearly through day 7 (Fig. 3B). Thus,
growth inhibition occurred in primary keratinocytes but
not in immortalized keratinocytes upon prolonged
treatment with CaCl2. In contrast, differentiation, the
other criterion for terminal differentiation, occurred
in both primary and immortalized keratinocytes upon
treatment with 1.2 mM CaCl2. Expression of the dif-
ferentiation marker, involucrin, was induced at day 1
and was further increased by day 7 with 1.2 mM CaCl2 in
primary keratinocytes (Fig. 3C). In immortalized kera-
tinocytes, involucrin expression was highly upregulated
at day 7 (Fig. 3E). Equivalency of loading was assayed by
blotting the same membrane with mouse anti-GAPDH
antibody (Fig. 3D and F, respectively). Thus, in normal
primary keratinocytes, 1.2 mM CaCl2 triggered both
Fig. 1. Autoradiograph of GTP-binding and ECL detection of rap1,
involucrin and GAPDH in cell lysates from sequential passages of
primary human oral keratinocytes. HOKs, passages 1, 2 and 3 (P1, P2,
P3; 8 104 cells/lane) were electrophoresed and transferred to
membranes that were incubated with [a-32P] GTP in GTP-binding
buffer with unlabelled 100 mM ATP minus (A) or with unlabeled
100 mM GTP (B). The membranes were exposed to film for 45 min. The
membrane that was previously incubated with cold GTP (B), was
subsequently exposed to rap1 antibody (C), developed, stripped
between successive antibodies, and successively tested with involucrin
(D), or GAPDH (E) antibodies as indicated. The rap1 data (C) were
normalized to GAPDH (E) and expressed as percent of GAPDH (F).
The immunoblot data are representative of three independent
experiments.
Fig. 2. Quantification of rap1A and rap1B mRNAs in sequential
passages of primary human oral keratinocytes. Total RNA was
prepared and real time RT-PCR was performed using the Perkin-
Elmer TaqMan system as described in the ‘‘Materials and Methods.’’
Rap1A and rap1B are normalized to b-actin. The data are the
meanSEM of four replicates in each of at least two independent
experiments. The data are representative of three independent
primary keratinocyte cell cultures.
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differentiation and cessation of proliferation, whereas
in immortalized keratinocytes, differentiation, but not
growth inhibition, was observed.
Taking advantage of this system, cell lysates were
prepared after treatment of primary and immortalized
HOKs with 0.03 or 1.2 mM CaCl2 for 3 or 7 days. In
primary keratinocytes rap1 activation, as assayed by an
increase in active GTP-bound rap1, increased from day 3
to day 7 in primary keratinocytes (Fig. 4A) in both 0.03
and 1.2 mM CaCl2-treated cells. In contrast, immorta-
Fig. 3. CaCl2-induced proliferation and differentiation of primary
and immortalized HOKs. Primary (A) or immortalized human oral
keratinocytes (B) were treated with 0.03 or 1.2 mM CaCl2 for 7 days
and proliferation was measured as described in ‘‘Materials and
Methods.’’ The values represent means of cell numberSD (in A
and B) based on 3 wells/data point in a single experiment. The
experiment is representative of three experiments with similar
results. Lysates from 0.03 or 1.2 mM CaCl2-treated primary or
immortalized keratinocytes, were electrophoresed and transferred to
membranes which were exposed to involucrin (C and E, respectively)
or GAPDH (D and F, respectively) antibodies. For primary keratino-
cytes, the involucrin signals at 7 day were much stronger than the 1-
day signals. Therefore, chemiluminographs of 7-day samples were
obtained after overnight decay of the substrate. The data are
representative of two independent experiments.
Fig. 4. Immunochemiluminescent detection of active GTP-bound
rap1, total rap1 and GAPDH in cell lysates from primary and
immortalized human oral keratinocytes treated with 0.03 and
1.2 mM CaCl2. Active GTP-bound rap1 was retrieved from lysates of
primary (400 mg) or immortalized (600 mg) keratinocytes using the
rap1 activation assay as described in ‘‘Materials and Methods.’’ The
retrieved active protein from the different treatment groups was
electrophoresed, transferred to membranes and exposed to rap1
antibody (A and D). To normalize the data to total rap1 and GAPDH,
corresponding cell lysates (20 mg) were electrophoresed and trans-
ferred to membranes, which were exposed to rap1 (B and E), or
GAPDH (C and F) antibodies. The data are representative of three
independent experiments.
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lized keratinocytes, which exhibit no growth inhibition,
exhibit minimal rap1 activation in both 0.03 and 1.2 mM
CaCl2-treated cells at day 3 and 7 (Fig. 4D). In both
primary and immortalized keratinocytes, there was no
significant change in total rap1 expression (Fig. 4B
and E, respectively) at equivalent protein loading, as
assessed by GAPDH (Fig. 4C and F, respectively), at
both days 3 and 7.
Rap1 does not coexpress with involucrin, a
differentiation marker
To verify the lack of association between rap1 and
differentiation, concurrent expression of rap1 and
involucrin was investigated by immunofluorescence
double labeling. Rap1 was detected in HOKs cultured
on Lab-Tek slides by FITC-labeled rabbit anti-rap1
polyclonal antibody, and involucrin was detected by
Texas Red-labeled mouse anti-involucrin antibody and
visualized by confocal microscopy (Fig. 5). These cell
cultures included both small undifferentiated and large
differentiated keratinocytes. Rap1 is strongly expressed
in the small, undifferentiated keratinocytes (Fig. 5A,B,
arrowheads). In contrast, the larger keratinocytes ex-
hibit strong expression of involucrin, a marker of differ-
entiation in HOKs, without a corresponding increase in
rap1 (Fig. 5A,B, arrows) (Dotto, 1999). In Figure 5C and
D, the rap1 and involucrin antibodies are shown alone
respectively with non-immune mouse IgG (Fig. 5C) and
non-immune rabbit IgG (Fig. 5D), the primary antibody
controls for involucrin and rap1, respectively. The non-
immune IgGs were appropriately negative thereby
indicating specificity of staining. Thus it can be seen in
this figure that some involucrin positive cells do not
strongly express rap1, suggesting that rap1 upregula-
tion and differentiation in keratinocytes are distinct and
separate processes.
RapGAP increases growth in
immortalized keratinocytes
Based on the preceding observations, we postulated
that rapGAP (rap-GTPase activating protein), a protein
that inactivates rap1-GTP, can enhance proliferation in
immortalized keratinocytes. As assessed by b-galacto-
sidase staining after 24 h, we obtained a transfection
efficiency of 10% with pcDNA 3.1-b-gal (Fig. 6A),
similar to that reported previously (Zellmer et al., 2001).
Immortalized keratinocytes were transfected with
pcDNA 3.1-rapGAP and assessed for effects on prolif-
eration. RapGAP expression in transfected keratino-
cytes was confirmed by immunoblot analysis (Fig. 6B)
which showed strong expression in pcDNA 3.1-rapGAP
transfected immortalized keratinocytes compared to the
control vector transfected cells. The total number of cells
and cell viability were assessed by trypan blue enumera-
tion assay. As shown in Figure 6C, an increase in the
total number of cells was observed in keratinocytes
transfected with rapGAP. By day 4, this increase was
significantly different (P<0.005) from the control vector
Fig. 5. Immunofluorescence detection of rap1 and involucrin in dual labeled immature and mature
differentiating primary human oral keratinocytes. P2 HOKs containing both small undifferentiated
and large differentiating keratinocytes were cultured on tissue culture slides. The cells were fixed and
dual labeled with rabbit anti-rap1 (A, B, C) or rabbit IgG (D) and mouse anti-involucrin (A, B, D) or mouse
IgG (C). Immunofluorescence detection was performed as described in ‘‘Methods and Materials’’
(Bar¼ 25 mm).
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(pcDNA 3.1) transfected cells. In contrast, there was
no significant difference in cell viability between cells
transfected with control vector or rapGAP, consistent
with an increase in cell number due to enhanced pro-
liferation with pcDNA-rapGAP rather than decreased
apoptosis in rapGAP transfected cells. Thus, active,
GTP-bound rap1 inhibits proliferation in keratinocytes.
DISCUSSION
In this report, the role of rap1 in differentiation and
proliferation in keratinocytes was examined. The major
findings of this study were that active GTP-bound rap1
inhibits proliferation, rap1 is upregulated with terminal
differentiation in primary oral keratinocytes, and that
in this process rap1B mRNA is more strongly expressed
than rap1A mRNA. From these observations it was
hypothesized, and subsequently shown that exogen-
ously expressed rapGAP, a protein that inactivates both
isoforms of rap1, enhances keratinocyte proliferation.
Therefore, rap1 may have an anti-proliferative role in
oral epithelium.
Rap1A and rap1B, the two rap1 isoforms have been
linked to a variety of biological functions, that appear to
vary by cell type. Interestingly, the same isoform has
been shown to have both tumorigenic and anti-tumori-
genic functions (Kitayama et al., 1989; Yoshida et al.,
1992). Several studies have been done in mesenchymal
cells, thus little is known about the function of the rap1
isoforms in epithelial cells. Since >80% of human
tumors are epithelial in origin, it is important to
characterize the role of these proteins in epithelial cells.
Human oral epithelium is a valuable model for studying
biochemical and molecular events that regulate or
accompany growth and differentiation. Although rap1
and other SMGs have been previously identified in
epidermal keratinocytes (Gromov and Celis, 1994), little
is known about the expression, regulation and function
of SMGs, other than ras isoforms, in epidermal or oral
keratinocytes.
Recently, Schmidt et al. (2000) suggested that a SMG,
other than ras, regulates differentiation in epidermal
keratinocytes via a Raf/Mek/Erk pathway. Earlier,
rap1B was shown to play a role in differentiation in
neuronal cells (Vossler et al., 1997; York et al., 1998).
These studies showed that in PC12 cells, rap1B
promotes differentiation by acting via the MAPK
pathway (Vossler et al., 1997; York et al., 1998).
Subsequently, Schmitt and Stork (2001) showed that
cAMP inhibits proliferation in NIH 3T3 cells by acting
via rap1. Hence, our initial studies focused on the role
of rap1 in terminal differentiation in primary oral
keratinocytes.
Keratinocytes undergoing terminal differentiation
cease to proliferate, and express biochemical markers
of terminal differentiation, such as involucrin, keratins
1 and 10 and filaggrin (Dotto, 1999). In vitro, attach-
ed keratinocytes can be induced to differentiate by
serial passaging or by treatment with 1.2 mM CaCl2
(Norsgaard et al., 1996; Dotto, 1999). However,
Norsgaard et al. (1996) reported that differentiation in
serially passaged epidermal keratinocytes did not occur
spontaneously but rather had to be induced by high
calcium concentrations. According to this study, in vitro,
keratinocytes senesce or cease to proliferate, but do
Fig. 6. Proliferation of immortalized keratinocytes transfected with
rapGAP. To evaluate transfection efficiency, immortalized human oral
keratinocytes were transfected with pcDNA 3.1-b-gal and evaluated
24 h later for b-galactosidase expression (A). Using identical con-
ditions, immortalized keratinocytes were transfected with pcDNA 3.1
-FLAG-rapGAP and control vector. Lysates were electrophoresed,
transferred, and exposed to the FLAG antibody to confirm rapGAP
expression (B). Proliferation of rapGAP or control vector transfected
keratinocytes was determined by a trypan blue enumeration assay
(C) as described in the ‘‘Materials and Methods.’’ The values represent
means of cell numberSD based on 2-wells/data point in a single
experiment. *Statistically significant data (P< 0.005; one-tailed
Student’s t-test). The experiment is representative of three experi-
ments with similar results.
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not necessarily differentiate, i.e., express biochemical
markers of terminal differentiation. However, in the
present study, differentiation, as monitored by increas-
ed expression of involucrin, and the loss of proliferative
capacity, occurred with sequential passaging. This dis-
parity between the studies may be related to differences
in culture conditions or to inherent differences between
epidermal and oral keratinocytes. Our studies showed
that rap1 expression increases with sequential passages
of primary keratinocytes.
Due to the large amount of protein required for rap1
activation assays, we were unable to assess rap1 acti-
vation in sequentially passaged primary keratinocytes,
which have an inadequate yield for the first and last
passages. Hence, we validated and used another in vitro
model for terminal differentiation, treating primary
keratinocytes with 1.2 mM CaCl2 for 7 days (Norsgaard
et al., 1996). In primary keratinocytes treated with high
concentrations (1.2 mM) of CaCl2, increased rap1 acti-
vation was observed only upon terminal differentia-
tion, i.e., upon cessation of proliferation in addition to
involucrin upregulation. An irreversible commitment to
differentiation takes more than 6 days of culture under
high (1.2 mM) CaCl2conditions (Norsgaard et al., 1996).
Under conditions reported here, 1.2 mM CaCl2 induced
proliferation between 1 and 3 days. Expression of active,
GTP-bound rap1 increased over the corresponding low
calcium control at 7 days, by which time proliferation
had ceased. Upregulation of active GTP-bound rap1 was
strongly correlated with inhibition of proliferation
and was observed at day 7, even under low calcium
conditions probably because of contact inhibition in a
confluent plate. Thus, rap1-GTP was upregulated con-
comitantly with growth cessation and differentiation in
both low and high calcium treated samples, but the
latter exhibited more prominent effects.
In contrast, active rap1-GTP expression was not
upregulated in immortalized keratinocytes upon treat-
ment with 1.2 mM CaCl2 for 7 days. Although these cells
expressed the differentiation marker, involucrin, con-
tinued proliferation was observed. Altogether, these
data suggest that rap1 activation is linked to growth
inhibition. Hence, though ras mutations are infre-
quently identified in oral cancer, our findings suggest
that an inactivating mutation in rap1, a protein that
antagonizes ras activity (Pessin and Okada, 1999),
would lead to uncontrolled proliferation of oral kerati-
nocytes.
The quantitative RT-PCR data suggest that neither
rap1 isoform is transcriptionally upregulated during
growth cessation, suggesting that the regulatory effect
is at the translational or catabolic stage. SMGs regulate
biochemical events by shuttling between membrane-
bound and soluble forms depending on whether these
proteins are in the active, GTP-bound or inactive, GDP-
bound state. In fact, we have previously shown that
rap1 plays a role in secretion in rat parotid acini by
translocating to the cytosolic fraction (Huber et al.,
1994). In the present study, the data suggest that the
increase in rap1 expression in the soluble fraction of
sequential passages of primary keratinocytes, is due to
translocation to the soluble fraction or due to effects on
protein translation or catabolism. Future studies will
explore these possibilities.
In summary, our data show that active, GTP-bound
rap1 inhibits proliferation in oral keratinocytes and
therefore, is a candidate protein for an anti-tumorigenic
role in oral epithelium.
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